FOI Request
- Disclosure ID
- FOI/00980
- Request Date
- May 18, 2016
- Subject
- Biologic Treament
- Description
In your Trust please supply the number of patients currently treated for Uveitis with a biologic treatment, including those on a Patient Access Scheme.
Please state the number of Uveitis patients treated, and where possible by each biologic drug:
- Adalimumab
- Etanercept
- Infliximab
- Rituximab
- Other biologics
How many Psoriasis patients have been treated in the last 6 months with Fumaric acid esters (Fumaderm), If your trust can’t supply patients, please supply the number of packs of tabs
- Response
Adalimumab Etanercept Infliximab Rituximab Others Total 0 2 0 0 0 2 112 11 12 6 49 190 74 69 0 0 0 143 44 0 17 0 0 61 0 0 0 0 0 230 82 29 6 49 396 * Total patients over 2 conditions